Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BloomWell Rx vs NowPatient

BloomWell Rx
Graded #298

Lower grade

vs+4.200000000000003
NowPatient
Graded #222

Higher grade

The verdict

NowPatient takes it — 65.5/100 to 61.3/100.

NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBloomWell Rx +19
54
35
Dose & formulationNowPatient +29
64
93
Clinical oversightNowPatient +15
71
86
Labs & monitoringNowPatient +1
53
54
FulfillmentEven
70
70
Contract termsEven
55
55
BloomWell Rx · left barNowPatient · right bar

The numbers

MetricBloomWell RxNowPatient
WeighScore61.3/10065.5/100
GradeCC
Scorecard rank#298#222
Semaglutide$199/mo (starting dose, compounded)$1,349/mo (brand Wegovy)
Tirzepatide$249/mo (starting dose, compounded)$1,069/mo (brand Mounjaro, promotional rate)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
BloomWell Rx

Graded #298 · C

Strengths

  • Transparent pricing — compounded semaglutide from $199/mo, tirzepatide (GLP-1/GIP) from $249/mo
  • Free initial visit; fully online process with flexible dosing options
  • Discloses meds are compounded by a licensed third-party pharmacy; also offers NAD+, sermorelin, glutathione
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)

Where it loses points

  • 'Starts at' pricing — final cost depends on dose and plan
  • Compounding pharmacy partner not named ('licensed third-party pharmacy')
  • Not LegitScript-certified (no certification displayed)
  • Operating medical entity not clearly named (site operated by a marketing agency)
NowPatient

Graded #222 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard